The Pistoia Alliance Advisory Board met on Wednesday 29th March. Steve Arlington, President of the Pistoia Alliance, invited its members to consider the biopharma and healthcare landscape as it might be in 2030.
There have been some exciting developments in the half-month since the Pistoia Alliance face-to-face meeting of the board and operational team. Just today, the fledgling working group on Biomarker Exchange Standards held its third meeting.
We don’t suffer a lack of ideas for potential Pistoia Alliance projects. The trick is getting a critical mass (including people and funds) behind an idea to turn it into an active project driving toward a solution.
The Pistoia Alliance is signposting the Hierarchical Editing Language for Macromolecules (HELM) developed at Pfizer as a way to solve the problem with how to consistently represent large molecules, such as proteins, peptides, oligonucleotides, and small molecule drugs.
The Pistoia Alliance App Strategy was outlined during a webinar presentation on 9 November. The presentation began with a brief overview of the three proposed phases of the Pistoia Alliance AppStore, and continued on with a lively question and answer session that covered all facets of our strategy and “appification” in life science R&D.
The Dragons’ Den session at the Pistoia Alliance Conference last April gave us a chance to socialize some of our embryonic portfolio projects.
Last week I was part of a very interesting email exchange on the topic of biomarker exchange standards. The correspondents were Sandor Szalma of Johnson & Johnson, who is heading up the embryonic working group on this subject, and James McGurk, director of informatics at Daiichi Sankyo Pharma Development.
Two teleconferences are planned for the next fortnight aiming to kick off working groups on two topics emanating from the highly fruitful Information Ecosystem Workshop that the Pistoia Alliance held last October in Hannover.
A few weeks ago, Drug Discovery World published our article on obstacles to innovation in pharma, which was informed by a great conversation on this blog in May.